Tessera Therapeutics
ID: 7648404Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ to drive advancements in genome engineering.
2
Funding Rounds
$530.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** (J**** Ru**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Tessera Therapeutics has raised a total of $530m in funding over 2 rounds.
Key Insights:
- Tessera Therapeutics Series C round, April 2022: $300m
- Tessera Therapeutics , January 2021: $230m
Industries
Tessera Therapeutics is active in the following industries: